Annals of Neurology,
Journal Year:
2023,
Volume and Issue:
95(2), P. 274 - 287
Published: Oct. 14, 2023
We
aimed
to
test
whether
region-specific
factors,
including
spatial
expression
patterns
of
the
tau-encoding
gene
MAPT
and
regional
levels
amyloid
positron
emission
tomography
(PET),
enhance
connectivity-based
modeling
variability
in
tau-PET
deposition
Alzheimer
disease
(AD)
spectrum.
Neuroglia,
Journal Year:
2025,
Volume and Issue:
6(2), P. 22 - 22
Published: May 6, 2025
This
review
synthesizes
the
emerging
understanding
of
roles
glial
cells
and
non-coding
RNAs
(ncRNAs)
in
pathogenesis
progression
Alzheimer’s
disease
related
dementias
(ADRDs).
ADRDs
encompass
a
spectrum
neurodegenerative
disorders
characterized
by
cognitive
decline,
memory
impairment,
functional
deterioration.
The
interplay
between
most
common
types
cells—astrocytes,
microglia,
oligodendrocytes—and
ncRNAs
is
as
critical
factor
development
ADRDs.
Glial
are
essential
for
maintaining
homeostasis
within
central
nervous
system
(CNS);
however,
their
dysregulation
can
lead
to
neuroinflammation
neuronal
dysfunction,
exacerbating
neurodegeneration.
Reactive
astrocytes
activated
microglia
create
neurotoxic
environments
that
further
impair
health.
Concurrently,
ncRNAs,
particularly
long
(lncRNAs)
microRNAs
(miRNAs),
have
emerged
significant
regulators
gene
expression,
influencing
inflammatory
responses
cell
function.
Understanding
complex
interactions
crucial
developing
targeted
therapeutic
strategies.
By
elucidating
mechanisms
underlying
interactions,
this
aims
highlight
importance
context
diseases,
paving
way
innovative
approaches
prevent
treat
Ultimately,
enhancing
our
these
processes
may
novel
therapies
improved
outcomes
individuals
affected
debilitating
conditions.
Current Opinion in Neurology,
Journal Year:
2023,
Volume and Issue:
36(5), P. 481 - 490
Published: Aug. 3, 2023
The
purpose
is
to
review
the
latest
advances
of
brain
imaging
for
diagnosis
Alzheimer
disease
(AD).Brain
techniques
provide
valuable
and
complementary
information
support
in
clinical
research
settings.
recent
FDA
accelerated
approvals
aducanumab,
lecanemab
donanemab
made
amyloid-PET
critical
helping
determine
optimal
window
anti-amyloid
therapeutic
interventions.
Tau-PET,
on
other
hand,
considered
key
importance
tracking
progression
monitoring
interventions
trials.
PET
microglial
activation,
astrocyte
reactivity
synaptic
degeneration
are
still
new
only
used
field,
more
studies
needed
validate
their
use
AD.
Finally,
artificial
intelligence
has
opened
prospective
early
detection
AD
using
MRI
modalities.Brain
improve
our
understanding
different
AD-related
pathologies
relationship
with
each
along
course
disease.
With
robust
validation,
machine
learning
deep
algorithms
could
be
integrated
neuroimaging
modalities
serve
as
tools
clinicians
make
prognosis
Frontiers in Aging Neuroscience,
Journal Year:
2023,
Volume and Issue:
15
Published: June 16, 2023
More
women
have
Alzheimer
disease
(AD)
than
men,
but
the
reasons
for
this
phenomenon
are
still
unknown.
Including
in
clinical
research
and
studying
their
biology
is
key
to
understand
not
just
increased
risk
also
resilience
against
disease.
In
sense,
more
affected
by
AD
reserve
or
mechanisms
might
delay
symptom
onset.
The
aim
of
review
was
explore
what
known
about
underlying
women’s
identify
emerging
themes
area
that
merit
further
research.
We
conducted
a
studies
analyzing
molecular
may
induce
neuroplasticity
women,
as
well
cognitive
brain
reserve.
analyzed
how
loss
steroid
hormones
aging
be
linked
AD.
included
empirical
with
human
animal
models,
literature
reviews
meta-analyses.
Our
search
identified
importance
17-b-estradiol
(E2)
mechanism
driving
women.
broadly,
our
analysis
revealed
following
perspectives:
(1)
effects
on
both
neurons
glia
study
AD,
(2)
E2’s
crucial
role
reserve,
(3)
verbal
memory
advantage
factor,
(4)
potential
linguistic
experiences
such
multilingualism
hearing
loss.
Future
directions
include
neuronal
glial
plasticity,
identifying
links
between
hormone
Annals of Neurology,
Journal Year:
2023,
Volume and Issue:
95(2), P. 274 - 287
Published: Oct. 14, 2023
We
aimed
to
test
whether
region-specific
factors,
including
spatial
expression
patterns
of
the
tau-encoding
gene
MAPT
and
regional
levels
amyloid
positron
emission
tomography
(PET),
enhance
connectivity-based
modeling
variability
in
tau-PET
deposition
Alzheimer
disease
(AD)
spectrum.